BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22499145)

  • 21. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 23. Allergen immunotherapy for allergic rhinitis.
    Okubo K; Gotoh M
    J Nippon Med Sch; 2010 Dec; 77(6):285-9. PubMed ID: 21206140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW; Passalacqua G
    Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
    J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
    Durham SR; Penagos M
    J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.
    Cox L
    Curr Allergy Asthma Rep; 2007 Nov; 7(6):410-20. PubMed ID: 17986370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.
    Gammeri E; Arena A; D'Anneo R; La Grutta S
    Allergol Immunopathol (Madr); 2005; 33(4):221-3. PubMed ID: 16045861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
    Klein F
    MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
    [No Abstract]   [Full Text] [Related]  

  • 30. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T; Klimek L
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract]   [Full Text] [Related]  

  • 31. Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.
    Pajno GB; Caminiti L; Passalacqua G
    Allergy Asthma Proc; 2013; 34(6):523-6. PubMed ID: 24169060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual immunotherapy.
    Lin SY; Leatherman B
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive effects of sublingual immunotherapy.
    Passalacqua G
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():83-6. PubMed ID: 19221627
    [No Abstract]   [Full Text] [Related]  

  • 36. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
    Rossi RE; Monasterolo G
    Int J Immunopathol Pharmacol; 2005; 18(2):277-85. PubMed ID: 15888250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult and pediatric clinical trials of sublingual immunotherapy in the USA.
    Park D; Daher N; Blaiss MS
    Expert Rev Clin Immunol; 2012 Aug; 8(6):557-64. PubMed ID: 22992150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for hayfever.
    Durham SR; Walker S
    Chem Immunol; 2000; 78():199-208. PubMed ID: 12847731
    [No Abstract]   [Full Text] [Related]  

  • 39. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe.
    Cox L; Calderon MA
    Curr Med Res Opin; 2010 Dec; 26(12):2723-33. PubMed ID: 20979432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.
    Dretzke J; Meadows A; Novielli N; Huissoon A; Fry-Smith A; Meads C
    J Allergy Clin Immunol; 2013 May; 131(5):1361-6. PubMed ID: 23557834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.